Capital Fund Management (CFM)
RDY icon

Capital Fund Management (CFM)’s Dr. Reddy's Laboratories RDY Stock Holding History

Capital Fund Management (CFM)’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,724
Closed -$236K – 2647
2025
Q2 		$236K Buy
+15,724
New +$225K ﹤0.01% 2299
2022
Q1 		– Sell
-55,370
Closed -$724K – 1735
2021
Q4 		$724K Sell
55,370
-11,365
-17% -$143K 0.01% 1370
2021
Q3 		$869K Buy
66,735
+8,095
+14% +$108K 0.01% 1232
2021
Q2 		$862K Sell
58,640
-570
-1% -$7.97K 0.01% 1193
2021
Q1 		$727K Sell
59,210
-1,390
-2% -$17.9K 0.01% 1047
2020
Q4 		$864K Sell
60,600
-22,125
-27% -$298K 0.01% 1034
2020
Q3 		$1.15M Sell
82,725
-2,880
-3% -$34.3K 0.01% 833
2020
Q2 		$908K Sell
85,605
-51,995
-38% -$529K 0.01% 725
2020
Q1 		$1.11M Buy
137,600
+71,370
+108% +$595K 0.02% 741
2019
Q4 		$538K Buy
+66,230
New +$523K ﹤0.01% 1359
2019
Q3 		– Sell
-35,500
Closed -$266K – 1848
2019
Q2 		$266K Buy
+35,500
New +$279K ﹤0.01% 1427
2018
Q3 		– Sell
-35,000
Closed -$225K – 2213
2018
Q2 		$225K Buy
+35,000
New +$221K ﹤0.01% 1878
2016
Q3 		– Sell
-295,000
Closed -$3.02M – 1758
2016
Q2 		$3.02M Buy
+295,000
New +$2.7M 0.03% 593
2015
Q3 		– Sell
-57,500
Closed -$636K – 1639
2015
Q2 		$636K Buy
+57,500
New +$635K 0.01% 989
2013
Q3 		– Sell
-83,500
Closed -$632K – 1841
2013
Q2 		$632K Buy
+83,500
New +$610K 0.01% 931

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital Fund Management (CFM)'s RDY Position: Q3 2025 in Review

Capital Fund Management (CFM) sold out of Dr. Reddy's Laboratories (RDY) in Q3 2025, closing a stake of 15,724 shares — an estimated $236K sold.

Capital Fund Management (CFM) first reported a position in RDY in Q2 2013 and held it in 15 quarters. The position peaked at $3.02M in Q2 2016. 228 funds tracked by Wall St. Rank hold RDY as of Q3 2025.

  • Capital Fund Management (CFM) reported no remaining Dr. Reddy's Laboratories position as of Q3 2025 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 15,724 Dr. Reddy's Laboratories shares in Q3 2025, an estimated $236K.
  • Capital Fund Management (CFM) first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 15 quarters.
  • Capital Fund Management (CFM)'s Dr. Reddy's Laboratories position peaked at $3.02M in Q2 2016.
  • 228 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2025.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2025, filed 13 Nov 2025.